Mineralys Therapeutics, Inc.
Mineralys Therapeutics, Inc. (MLYS) is a publicly traded company in the Unknown sector. Across all available filings, 14 corporate insiders have executed 143 transactions totaling $174.5M, demonstrating a bullish sentiment with $18.9M in net insider flow. The most recent transaction on Feb 19, 2026 involved a transaction of 53,300 shares valued at $0.
MLYS Insider Activity Summary
Who Is Buying MLYS Stock?
No significant insider buying has been recorded for MLYS in the recent period.
Who Is Selling MLYS Stock?
No significant insider selling has been recorded for MLYS in the recent period.
Is Mineralys Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for MLYS is bullish with an Insider Alignment Score of 55/100 and a net flow of $18.9M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
MLYS Frequently Asked Questions
Understanding MLYS Insider Activity
Insider trading at Mineralys Therapeutics, Inc. (MLYS) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 14 insiders are actively trading MLYS stock, having executed 143 transactions in the past 90 days. The most active insider is Capital Management, L.p. Ra (Executive), who has made 4 transactions totaling $52.6M.
Related Tools
Track Mineralys Therapeutics, Inc. Insider Activity
Get notified when executives and directors at MLYS file new Form 4 transactions